The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5.
It’s now limited to those 18 and older “for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate,” the FDA’s statement said. Additionally, those 18 and older can opt to get the J&J shot if “they would otherwise not receive a COVID-19 vaccine.”
Janssen Pharmaceuticals said “our number one priority is the safety and well-being of those who use the Johnson & Johnson COVID-19 vaccine,” in a statement provided to McClatchy News and noted its fact sheet on the single-dose shot has been updated in coordination with the FDA.
